此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

在患有晚期胰腺神经内分泌肿瘤和类癌肿瘤的患者中测试卡博替尼

2026年11月11日 更新者:National Cancer Institute (NCI)

卡博替尼与安慰剂在既往治疗进展后晚期神经内分泌肿瘤患者中的随机、双盲 III 期研究 (CABINET)

This phase III trial studies cabozantinib to see how well it works compared with placebo in treating patients with neuroendocrine or carcinoid tumors that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Cabozantinib is a chemotherapy drug known as a tyrosine kinase inhibitor, and it targets specific tyrosine kinase receptors, that when blocked, may slow tumor growth.

研究概览

详细说明

PRIMARY OBJECTIVES:

I. To determine whether cabozantinib (cabozantinib S-malate) can significantly improve progression-free survival (PFS) compared to placebo in patients with advanced pancreatic neuroendocrine tumors (NET) whose disease has progressed after prior therapy.

II. To determine whether cabozantinib can significantly improve progression-free survival (PFS) compared to placebo in patients with advanced carcinoid tumors whose disease has progressed after prior therapy.

SECONDARY OBJECTIVES:

I. To determine whether cabozantinib can significantly improve overall survival (OS) compared to placebo in patients with advanced pancreatic NET whose disease has progressed after prior therapy.

II. To determine whether cabozantinib can significantly improve overall survival (OS) compared to placebo in patients with advanced carcinoid tumors whose disease has progressed after prior therapy.

III. To evaluate safety and tolerability of cabozantinib versus placebo in patients with advanced pancreatic NET using Common Terminology Criteria for Adverse Events (CTCAE) and Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

IV. To evaluate safety and tolerability of cabozantinib versus placebo in patients with advanced carcinoid tumors using CTCAE and PRO-CTCAE.

V. To evaluate the overall radiographic response rate of cabozantinib versus placebo in patients with advanced pancreatic NET whose disease has progressed after prior therapy.

VI. To evaluate the overall radiographic response rate of cabozantinib versus placebo in patients with advanced carcinoid tumors whose disease has progressed after prior therapy.

OTHER OBJECTIVE:

I. Results of the primary analysis will be examined for consistency, while taking into account the stratification factors and/or covariates of baseline quality of life (QOL) and fatigue.

QUALITY OF LIFE SUBSTUDY OBJECTIVE:

I. To compare overall quality of life, disease-related symptoms, and other domains between the two treatment groups (cabozantinib versus [vs.] placebo) within each cohort of patients (pancreatic NET vs. carcinoid tumor). (Quality of Life Substudy Objective - A021602-HO1)

POPULATION PHARMACOKINETICS SUBSTUDY OBJECTIVE:

I. To describe the population pharmacokinetic and exposure-response relationships of cabozantinib in patients with advanced neuroendocrine tumors. (Population Pharmacokinetics Substudy Objective - A021602-PP1)

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive cabozantinib S-malate orally (PO) once daily (QD) on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo blood and urine sample collection, and computed tomography (CT), magnetic resonance imaging (MRI), and/or x-ray imaging during screening and on study.

ARM II: Patients receive placebo PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo blood and urine sample collection, and CT, MRI, and/or x-ray imaging during screening and on study. Patients may crossover to receive cabozantinib S-malate at the time of disease progression.

After completion of study treatment, patients are followed up every 12 weeks until disease progression or start of new anticancer therapy, and then every 6 months until 8 years after registration.

研究类型

介入性

注册 (实际的)

298

阶段

  • 第三阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Alaska
      • Anchorage、Alaska、美国、99508
        • Katmai Oncology Group
    • Arizona
      • Kingman、Arizona、美国、86401
        • Kingman Regional Medical Center
      • Phoenix、Arizona、美国、85054
        • Mayo Clinic Hospital in Arizona
      • Tucson、Arizona、美国、85719
        • Banner University Medical Center - Tucson
      • Tucson、Arizona、美国、85719
        • University of Arizona Cancer Center-North Campus
    • Arkansas
      • Little Rock、Arkansas、美国、72205
        • University of Arkansas for Medical Sciences
    • California
      • Antioch、California、美国、94531
        • Kaiser Permanente-Deer Valley Medical Center
      • Arroyo Grande、California、美国、93420
        • PCR Oncology
      • Auburn、California、美国、95602
        • Sutter Auburn Faith Hospital
      • Berkeley、California、美国、94704
        • Alta Bates Summit Medical Center-Herrick Campus
      • Burlingame、California、美国、94010
        • Mills-Peninsula Medical Center
      • Duarte、California、美国、91010
        • City of Hope Comprehensive Cancer Center
      • Dublin、California、美国、94568
        • Epic Care-Dublin
      • Emeryville、California、美国、94608
        • Epic Care Partners in Cancer Care
      • Fremont、California、美国、94538
        • Kaiser Permanente-Fremont
      • Fremont、California、美国、94538
        • Palo Alto Medical Foundation-Fremont
      • Fresno、California、美国、93720
        • Kaiser Permanente-Fresno
      • Martinez、California、美国、94553-3156
        • Contra Costa Regional Medical Center
      • Marysville、California、美国、95901
        • Fremont - Rideout Cancer Center
      • Modesto、California、美国、95355
        • Memorial Medical Center
      • Modesto、California、美国、95356
        • Kaiser Permanente-Modesto
      • Mountain View、California、美国、94040
        • Palo Alto Medical Foundation-Camino Division
      • Oakland、California、美国、94611
        • Kaiser Permanente-Oakland
      • Oakland、California、美国、94609
        • Alta Bates Summit Medical Center - Summit Campus
      • Palo Alto、California、美国、94304
        • Stanford Cancer Institute Palo Alto
      • Palo Alto、California、美国、94301
        • Palo Alto Medical Foundation Health Care
      • Redwood City、California、美国、94063
        • Kaiser Permanente-Redwood City
      • Richmond、California、美国、94801
        • Kaiser Permanente-Richmond
      • Roseville、California、美国、95661
        • Kaiser Permanente-Roseville
      • Roseville、California、美国、95661
        • Sutter Roseville Medical Center
      • Sacramento、California、美国、95816
        • Sutter Medical Center Sacramento
      • Sacramento、California、美国、95817
        • University of California Davis Comprehensive Cancer Center
      • Sacramento、California、美国、95814
        • Kaiser Permanente Downtown Commons
      • Sacramento、California、美国、95823
        • Kaiser Permanente-South Sacramento
      • Salinas、California、美国、93901
        • Salinas Valley Memorial
      • San Francisco、California、美国、94115
        • Kaiser Permanente-San Francisco
      • San Francisco、California、美国、94158
        • UCSF Medical Center-Mission Bay
      • San Francisco、California、美国、94115
        • California Pacific Medical Center-Pacific Campus
      • San Jose、California、美国、95119
        • Kaiser Permanente-Santa Teresa-San Jose
      • San Leandro、California、美国、94577
        • Kaiser Permanente San Leandro
      • San Mateo、California、美国、94401
        • Mills Health Center
      • San Rafael、California、美国、94903
        • Kaiser San Rafael-Gallinas
      • San Rafael、California、美国、94903
        • Kaiser Permanente-San Rafael
      • Santa Clara、California、美国、95051
        • Kaiser Permanente Medical Center - Santa Clara
      • Santa Cruz、California、美国、95065
        • Palo Alto Medical Foundation-Santa Cruz
      • Santa Rosa、California、美国、95403
        • Kaiser Permanente-Santa Rosa
      • South San Francisco、California、美国、94080
        • Kaiser Permanente-South San Francisco
      • Stockton、California、美国、95210
        • Kaiser Permanente-Stockton
      • Sunnyvale、California、美国、94086
        • Palo Alto Medical Foundation-Sunnyvale
      • Vacaville、California、美国、95688
        • Kaiser Permanente Medical Center-Vacaville
      • Vallejo、California、美国、94589
        • Kaiser Permanente-Vallejo
      • Vallejo、California、美国、94589
        • Sutter Solano Medical Center/Cancer Center
      • Walnut Creek、California、美国、94596
        • Kaiser Permanente-Walnut Creek
    • Colorado
      • Aurora、Colorado、美国、80012
        • Rocky Mountain Cancer Centers-Aurora
      • Boulder、Colorado、美国、80304
        • Rocky Mountain Cancer Centers-Boulder
      • Colorado Springs、Colorado、美国、80907
        • Penrose-Saint Francis Healthcare
      • Denver、Colorado、美国、80218
        • Rocky Mountain Cancer Centers-Midtown
      • Denver、Colorado、美国、80220
        • Rocky Mountain Cancer Centers-Rose
      • Denver、Colorado、美国、80206
        • National Jewish Health-Main Campus
      • Denver、Colorado、美国、80218
        • Saint Joseph Hospital - Cancer Centers of Colorado
      • Englewood、Colorado、美国、80113
        • Mountain Blue Cancer Care Center - Swedish
      • Englewood、Colorado、美国、80113
        • Swedish Medical Center
      • Golden、Colorado、美国、80401
        • National Jewish Health-Western Hematology Oncology
      • Grand Junction、Colorado、美国、81501
        • Saint Mary's Hospital and Regional Medical Center
      • Greeley、Colorado、美国、80631
        • Banner North Colorado Medical Center
      • Lafayette、Colorado、美国、80026
        • Good Samaritan Hospital - Cancer Centers of Colorado
      • Littleton、Colorado、美国、80120
        • Rocky Mountain Cancer Centers-Littleton
      • Lone Tree、Colorado、美国、80124
        • Rocky Mountain Cancer Centers-Sky Ridge
      • Loveland、Colorado、美国、80539
        • Banner North Colorado Medical Center - Loveland Campus
      • Thornton、Colorado、美国、80260
        • National Jewish Health-Northern Hematology Oncology
      • Wheat Ridge、Colorado、美国、80401
        • Intermountain Health Lutheran Hospital
    • Connecticut
      • Danbury、Connecticut、美国、06810
        • Danbury Hospital
      • Norwalk、Connecticut、美国、06856
        • Norwalk Hospital
    • District of Columbia
      • Washington D.C.、District of Columbia、美国、20007
        • MedStar Georgetown University Hospital
    • Florida
      • Aventura、Florida、美国、33180
        • GenesisCare USA - Aventura FP
      • Aventura、Florida、美国、33180
        • GenesisCare USA - Aventura
      • Boca Raton、Florida、美国、33431
        • GenesisCare USA - Boca Ration FP06
      • Fort Myers、Florida、美国、33905
        • Regional Cancer Center-Lee Memorial Health System
      • Hollywood、Florida、美国、33021
        • Memorial Regional Hospital/Joe DiMaggio Children's Hospital
      • Jacksonville、Florida、美国、32224-9980
        • Mayo Clinic in Florida
      • Tampa、Florida、美国、33612
        • Moffitt Cancer Center
    • Georgia
      • Atlanta、Georgia、美国、30308
        • Emory University Hospital Midtown
      • Atlanta、Georgia、美国、30322
        • Emory University Hospital/Winship Cancer Institute
      • Atlanta、Georgia、美国、30342
        • Emory Saint Joseph's Hospital
    • Hawaii
      • Honolulu、Hawaii、美国、96813
        • Queen's Medical Center
      • Honolulu、Hawaii、美国、96813
        • Hawaii Cancer Care Inc - Waterfront Plaza
      • Honolulu、Hawaii、美国、96813
        • Queen's Cancer Cenrer - POB I
      • Honolulu、Hawaii、美国、96813
        • Straub Clinic and Hospital
      • Honolulu、Hawaii、美国、96817
        • Queen's Cancer Center - Kuakini
      • Honolulu、Hawaii、美国、96819
        • Kaiser Permanente Moanalua Medical Center
      • ‘Aiea、Hawaii、美国、96701
        • Hawaii Cancer Care - Westridge
      • ‘Aiea、Hawaii、美国、96701
        • Pali Momi Medical Center
    • Idaho
      • Boise、Idaho、美国、83706
        • Saint Alphonsus Cancer Care Center-Boise
      • Boise、Idaho、美国、83712
        • Saint Luke's Cancer Institute - Boise
      • Caldwell、Idaho、美国、83605
        • Saint Alphonsus Cancer Care Center-Caldwell
      • Coeur d'Alene、Idaho、美国、83814
        • Kootenai Health - Coeur d'Alene
      • Emmett、Idaho、美国、83617
        • Walter Knox Memorial Hospital
      • Fruitland、Idaho、美国、83619
        • Saint Luke's Cancer Institute - Fruitland
      • Meridian、Idaho、美国、83642
        • Idaho Urologic Institute-Meridian
      • Meridian、Idaho、美国、83642
        • Saint Luke's Cancer Institute - Meridian
      • Nampa、Idaho、美国、83687
        • Saint Alphonsus Cancer Care Center-Nampa
      • Nampa、Idaho、美国、83687
        • Saint Luke's Cancer Institute - Nampa
      • Post Falls、Idaho、美国、83854
        • Kootenai Clinic Cancer Services - Post Falls
      • Sandpoint、Idaho、美国、83864
        • Kootenai Clinic Cancer Services - Sandpoint
      • Twin Falls、Idaho、美国、83301
        • Saint Luke's Cancer Institute - Twin Falls
    • Illinois
      • Bloomington、Illinois、美国、61704
        • Illinois CancerCare-Bloomington
      • Canton、Illinois、美国、61520
        • Illinois CancerCare-Canton
      • Carthage、Illinois、美国、62321
        • Illinois CancerCare-Carthage
      • Chicago、Illinois、美国、60637
        • University of Chicago Comprehensive Cancer Center
      • Chicago、Illinois、美国、60612
        • University of Illinois
      • Danville、Illinois、美国、61832
        • Carle at The Riverfront
      • Decatur、Illinois、美国、62526
        • Cancer Care Specialists of Illinois - Decatur
      • Dixon、Illinois、美国、61021
        • Illinois CancerCare-Dixon
      • Effingham、Illinois、美国、62401
        • Crossroads Cancer Center
      • Effingham、Illinois、美国、62401
        • Carle Physician Group-Effingham
      • Eureka、Illinois、美国、61530
        • Illinois CancerCare-Eureka
      • Galesburg、Illinois、美国、61401
        • Illinois CancerCare-Galesburg
      • Kewanee、Illinois、美国、61443
        • Illinois CancerCare-Kewanee Clinic
      • Macomb、Illinois、美国、61455
        • Illinois CancerCare-Macomb
      • Mattoon、Illinois、美国、61938
        • Carle Physician Group-Mattoon/Charleston
      • Maywood、Illinois、美国、60153
        • Loyola University Medical Center
      • New Lenox、Illinois、美国、60451
        • UC Comprehensive Cancer Center at Silver Cross
      • O'Fallon、Illinois、美国、62269
        • Cancer Care Center of O'Fallon
      • Orland Park、Illinois、美国、60462
        • University of Chicago Medicine-Orland Park
      • Ottawa、Illinois、美国、61350
        • Illinois CancerCare-Ottawa Clinic
      • Pekin、Illinois、美国、61554
        • Illinois CancerCare-Pekin
      • Peoria、Illinois、美国、61615
        • Illinois CancerCare-Peoria
      • Peru、Illinois、美国、61354
        • Illinois CancerCare-Peru
      • Princeton、Illinois、美国、61356
        • Illinois CancerCare-Princeton
      • Springfield、Illinois、美国、62702
        • Southern Illinois University School of Medicine
      • Springfield、Illinois、美国、62702
        • Springfield Clinic
      • Urbana、Illinois、美国、61801
        • Carle Cancer Center
      • Washington、Illinois、美国、61571
        • Illinois CancerCare - Washington
    • Indiana
      • South Bend、Indiana、美国、46601
        • Memorial Hospital of South Bend
    • Iowa
      • Bettendorf、Iowa、美国、52722
        • University of Iowa Healthcare Cancer Services Quad Cities
      • Cedar Rapids、Iowa、美国、52403
        • Mercy Hospital
      • Cedar Rapids、Iowa、美国、52403
        • Oncology Associates at Mercy Medical Center
      • Clive、Iowa、美国、50325
        • Mercy Cancer Center-West Lakes
      • Clive、Iowa、美国、50325
        • UI Health Care Mission Cancer and Blood - West Des Moines Clinic
      • Council Bluffs、Iowa、美国、51503
        • Heartland Oncology and Hematology LLP
      • Council Bluffs、Iowa、美国、51503
        • Methodist Jennie Edmundson Hospital
      • Creston、Iowa、美国、50801
        • Greater Regional Medical Center
      • Des Moines、Iowa、美国、50309
        • Iowa Methodist Medical Center
      • Des Moines、Iowa、美国、50314
        • Mercy Medical Center - Des Moines
      • Des Moines、Iowa、美国、50314
        • Broadlawns Medical Center
      • Des Moines、Iowa、美国、50309
        • UI Health Care Mission Cancer and Blood - Des Moines Clinic
      • Des Moines、Iowa、美国、50314
        • UI Health Care Mission Cancer and Blood - Laurel Clinic
      • Fort Dodge、Iowa、美国、50501
        • UI Healthcare Mission Cancer and Blood - Fort Dodge
      • Iowa City、Iowa、美国、52242
        • University of Iowa/Holden Comprehensive Cancer Center
      • West Des Moines、Iowa、美国、50266
        • Mercy Medical Center-West Lakes
    • Kentucky
      • Lexington、Kentucky、美国、40536
        • University of Kentucky/Markey Cancer Center
    • Louisiana
      • Baton Rouge、Louisiana、美国、70805
        • LSU Health Baton Rouge-North Clinic
      • Baton Rouge、Louisiana、美国、70809
        • Louisiana Hematology Oncology Associates LLC
      • Baton Rouge、Louisiana、美国、70809
        • Mary Bird Perkins Cancer Center
      • Baton Rouge、Louisiana、美国、70808
        • Our Lady of The Lake
      • Baton Rouge、Louisiana、美国、70808
        • Our Lady of the Lake Physician Group
      • Covington、Louisiana、美国、70433
        • Northshore Oncology Associates-Covington
      • Houma、Louisiana、美国、70360
        • Oncology Center of The South Incorporated
    • Massachusetts
      • Boston、Massachusetts、美国、02215
        • Beth Israel Deaconess Medical Center
      • Boston、Massachusetts、美国、02215
        • Dana-Farber Cancer Institute
      • Boston、Massachusetts、美国、02115
        • Brigham and Women's Hospital
      • Boston、Massachusetts、美国、02118
        • Boston Medical Center
      • Burlington、Massachusetts、美国、01805
        • Lahey Clinic
    • Michigan
      • Adrian、Michigan、美国、49221
        • Hickman Cancer Center
      • Ann Arbor、Michigan、美国、48109
        • University of Michigan Rogel Cancer Center
      • Ann Arbor、Michigan、美国、48106
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
      • Battle Creek、Michigan、美国、49017
        • Bronson Battle Creek
      • Brighton、Michigan、美国、48114
        • Trinity Health IHA Medical Group Hematology Oncology - Brighton
      • Brighton、Michigan、美国、48114
        • Trinity Health Medical Center - Brighton
      • Canton、Michigan、美国、48188
        • Trinity Health IHA Medical Group Hematology Oncology - Canton
      • Canton、Michigan、美国、48188
        • Trinity Health Medical Center - Canton
      • Caro、Michigan、美国、48723
        • Caro Cancer Center
      • Chelsea、Michigan、美国、48118
        • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
      • Chelsea、Michigan、美国、48118
        • Chelsea Hospital
      • Clarkston、Michigan、美国、48346
        • McLaren Cancer Institute-Clarkston
      • Clarkston、Michigan、美国、48346
        • Hematology Oncology Consultants-Clarkston
      • Clarkston、Michigan、美国、48346
        • Newland Medical Associates-Clarkston
      • Detroit、Michigan、美国、48202
        • Henry Ford Hospital
      • Detroit、Michigan、美国、48201
        • Wayne State University/Karmanos Cancer Institute
      • Detroit、Michigan、美国、48236
        • Henry Ford Health Saint John Hospital
      • East China Township、Michigan、美国、48054
        • Henry Ford River District Hospital
      • Farmington Hills、Michigan、美国、48334
        • Weisberg Cancer Treatment Center
      • Flint、Michigan、美国、48532
        • McLaren Cancer Institute-Flint
      • Flint、Michigan、美国、48532
        • Singh and Arora Hematology Oncology PC
      • Flint、Michigan、美国、48503
        • Hurley Medical Center
      • Flint、Michigan、美国、48503
        • Genesee Hematology Oncology PC
      • Flint、Michigan、美国、48503
        • Genesys Hurley Cancer Institute
      • Flint、Michigan、美国、48503
        • Cancer Hematology Centers - Flint
      • Grosse Pointe Woods、Michigan、美国、48236
        • Henry Ford Saint John Hospital - Academic
      • Grosse Pointe Woods、Michigan、美国、48236
        • Henry Ford Saint John Hospital - Breast
      • Grosse Pointe Woods、Michigan、美国、48236
        • Henry Ford Saint John Hospital - Van Elslander
      • Kalamazoo、Michigan、美国、49007
        • West Michigan Cancer Center
      • Kalamazoo、Michigan、美国、49007
        • Bronson Methodist Hospital
      • Kalamazoo、Michigan、美国、49009
        • Beacon Kalamazoo Cancer Center
      • Lansing、Michigan、美国、48910
        • Karmanos Cancer Institute at McLaren Greater Lansing
      • Lansing、Michigan、美国、48912
        • University of Michigan Health - Sparrow Lansing
      • Livonia、Michigan、美国、48154
        • Trinity Health Saint Mary Mercy Livonia Hospital
      • Livonia、Michigan、美国、48154
        • Hope Cancer Clinic
      • Macomb、Michigan、美国、48044
        • Henry Ford Warren Hospital - Breast Macomb
      • Macomb、Michigan、美国、48044
        • Henry Ford Saint John Hospital - Macomb Medical
      • Marlette、Michigan、美国、48453
        • Saint Mary's Oncology/Hematology Associates of Marlette
      • Monroe、Michigan、美国、48162
        • Toledo Clinic Cancer Centers-Monroe
      • Mount Clemens、Michigan、美国、48043
        • McLaren Cancer Institute-Macomb
      • Mount Pleasant、Michigan、美国、48858
        • McLaren Cancer Institute-Central Michigan
      • Petoskey、Michigan、美国、49770
        • McLaren Cancer Institute-Northern Michigan
      • Pontiac、Michigan、美国、48341
        • Hope Cancer Center
      • Pontiac、Michigan、美国、48341
        • Trinity Health Saint Joseph Mercy Oakland Hospital
      • Pontiac、Michigan、美国、48341
        • Michigan Healthcare Professionals Pontiac
      • Pontiac、Michigan、美国、48341
        • Trinity Health IHA Medical Group-Alice Gustafson Center
      • Port Huron、Michigan、美国、48060
        • McLaren-Port Huron
      • Port Huron、Michigan、美国、48060
        • Lake Huron Medical Center
      • Port Huron、Michigan、美国、48060
        • Huron Medical Center PC
      • Rochester Hills、Michigan、美国、48309
        • Henry Ford Rochester Hospital
      • Saginaw、Michigan、美国、48604
        • Oncology Hematology Associates of Saginaw Valley PC
      • Saginaw、Michigan、美国、48601
        • MyMichigan Medical Center Saginaw
      • Sterling Heights、Michigan、美国、48312
        • Bhadresh Nayak MD PC-Sterling Heights
      • Tawas City、Michigan、美国、48764
        • MyMichigan Medical Center Tawas
      • Warren、Michigan、美国、48088
        • Advanced Breast Care Center PLLC
      • Warren、Michigan、美国、48093
        • Macomb Hematology Oncology PC
      • Warren、Michigan、美国、48093
        • Henry Ford Madison Heights Hospital - Breast
      • Warren、Michigan、美国、48093
        • Henry Ford Health Warren Hospital
      • Warren、Michigan、美国、48093
        • Henry Ford Warren Hospital - GLCMS
      • West Branch、Michigan、美国、48661
        • Saint Mary's Oncology/Hematology Associates of West Branch
      • Ypsilanti、Michigan、美国、48197
        • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
      • Ypsilanti、Michigan、美国、48106
        • Huron Gastroenterology PC
    • Minnesota
      • Bemidji、Minnesota、美国、56601
        • Sanford Joe Lueken Cancer Center
      • Burnsville、Minnesota、美国、55337
        • Fairview Ridges Hospital
      • Burnsville、Minnesota、美国、55337
        • Minnesota Oncology - Burnsville
      • Coon Rapids、Minnesota、美国、55433
        • Mercy Hospital
      • Deer River、Minnesota、美国、56636
        • Essentia Health - Deer River Clinic
      • Duluth、Minnesota、美国、55805
        • Essentia Health Cancer Center
      • Edina、Minnesota、美国、55435
        • Fairview Southdale Hospital
      • Fridley、Minnesota、美国、55432
        • Unity Hospital
      • Hibbing、Minnesota、美国、55746
        • Essentia Health Hibbing Clinic
      • Maple Grove、Minnesota、美国、55369
        • Fairview Clinics and Surgery Center Maple Grove
      • Maplewood、Minnesota、美国、55109
        • Saint John's Hospital - Healtheast
      • Maplewood、Minnesota、美国、55109
        • Minnesota Oncology Hematology PA-Maplewood
      • Minneapolis、Minnesota、美国、55415
        • Hennepin County Medical Center
      • Minneapolis、Minnesota、美国、55407
        • Abbott-Northwestern Hospital
      • Minneapolis、Minnesota、美国、55454
        • Health Partners Inc
      • New Ulm、Minnesota、美国、56073
        • New Ulm Medical Center
      • Robbinsdale、Minnesota、美国、55422
        • North Memorial Medical Health Center
      • Rochester、Minnesota、美国、55905
        • Mayo Clinic in Rochester
      • Saint Louis Park、Minnesota、美国、55416
        • Park Nicollet Clinic - Saint Louis Park
      • Saint Paul、Minnesota、美国、55101
        • Regions Hospital
      • Saint Paul、Minnesota、美国、55102
        • United Hospital
      • Sandstone、Minnesota、美国、55072
        • Essentia Health Sandstone
      • Shakopee、Minnesota、美国、55379
        • Saint Francis Regional Medical Center
      • Stillwater、Minnesota、美国、55082
        • Lakeview Hospital
      • Virginia、Minnesota、美国、55792
        • Essentia Health Virginia Clinic
      • Waconia、Minnesota、美国、55387
        • Ridgeview Medical Center
      • Willmar、Minnesota、美国、56201
        • Rice Memorial Hospital
      • Woodbury、Minnesota、美国、55125
        • Minnesota Oncology Hematology PA-Woodbury
      • Wyoming、Minnesota、美国、55092
        • Fairview Lakes Medical Center
    • Missouri
      • Bonne Terre、Missouri、美国、63628
        • Parkland Health Center-Bonne Terre
      • Cape Girardeau、Missouri、美国、63703
        • Saint Francis Medical Center
      • City of Saint Peters、Missouri、美国、63376
        • Siteman Cancer Center at Saint Peters Hospital
      • Creve Coeur、Missouri、美国、63141
        • Siteman Cancer Center at West County Hospital
      • Farmington、Missouri、美国、63640
        • Parkland Health Center - Farmington
      • Sainte Genevieve、Missouri、美国、63670
        • Sainte Genevieve County Memorial Hospital
      • St Louis、Missouri、美国、63110
        • Washington University School of Medicine
      • St Louis、Missouri、美国、63129
        • Siteman Cancer Center-South County
      • St Louis、Missouri、美国、63136
        • Siteman Cancer Center at Christian Hospital
      • St Louis、Missouri、美国、63131
        • Missouri Baptist Medical Center
      • Sullivan、Missouri、美国、63080
        • Missouri Baptist Sullivan Hospital
    • Montana
      • Anaconda、Montana、美国、59711
        • Community Hospital of Anaconda
      • Billings、Montana、美国、59101
        • Billings Clinic Cancer Center
      • Billings、Montana、美国、59102
        • Saint Vincent Frontier Cancer Center
      • Bozeman、Montana、美国、59715
        • Bozeman Health Deaconess Hospital
      • Butte、Montana、美国、59701
        • Saint James Community Hospital and Cancer Treatment Center
      • Great Falls、Montana、美国、59405
        • Great Falls Clinic
      • Great Falls、Montana、美国、59405
        • Benefis Sletten Cancer Institute
      • Helena、Montana、美国、59601
        • Saint Peter's Community Hospital
      • Kalispell、Montana、美国、59901
        • Logan Health Medical Center
      • Missoula、Montana、美国、59804
        • Community Medical Center
    • Nebraska
      • Grand Island、Nebraska、美国、68803
        • Nebraska Cancer Specialists/Oncology Hematology West PC
      • Omaha、Nebraska、美国、68114
        • Nebraska Methodist Hospital
      • Omaha、Nebraska、美国、68114
        • Oncology Associates PC
      • Omaha、Nebraska、美国、68114
        • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC
    • Nevada
      • Carson City、Nevada、美国、89703
        • Carson Tahoe Regional Medical Center
      • Henderson、Nevada、美国、89052
        • Comprehensive Cancer Centers of Nevada - Henderson
      • Henderson、Nevada、美国、89052
        • Cancer and Blood Specialists-Henderson
      • Henderson、Nevada、美国、89052
        • Las Vegas Cancer Center-Henderson
      • Henderson、Nevada、美国、89074
        • Comprehensive Cancer Centers of Nevada-Southeast Henderson
      • Henderson、Nevada、美国、89052
        • Comprehensive Cancer Centers of Nevada-Horizon Ridge
      • Henderson、Nevada、美国、89074
        • Oncology Las Vegas - Henderson
      • Las Vegas、Nevada、美国、89144
        • Summerlin Hospital Medical Center
      • Las Vegas、Nevada、美国、89102
        • OptumCare Cancer Care at Charleston
      • Las Vegas、Nevada、美国、89106
        • Radiation Oncology Centers of Nevada Central
      • Las Vegas、Nevada、美国、89119
        • Radiation Oncology Centers of Nevada Southeast
      • Las Vegas、Nevada、美国、89128
        • Comprehensive Cancer Centers of Nevada - Northwest
      • Las Vegas、Nevada、美国、89128
        • OptumCare Cancer Care at MountainView
      • Las Vegas、Nevada、美国、89144
        • Comprehensive Cancer Centers of Nevada-Summerlin
      • Las Vegas、Nevada、美国、89148
        • Comprehensive Cancer Centers of Nevada
      • Las Vegas、Nevada、美国、89169
        • Comprehensive Cancer Centers of Nevada - Central Valley
      • Las Vegas、Nevada、美国、89102
        • University Medical Center of Southern Nevada
      • Las Vegas、Nevada、美国、89106
        • Cancer and Blood Specialists-Shadow
      • Las Vegas、Nevada、美国、89109
        • HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway
      • Las Vegas、Nevada、美国、89113
        • HealthCare Partners Medical Group Oncology/Hematology-San Martin
      • Las Vegas、Nevada、美国、89121
        • Cancer Therapy and Integrative Medicine
      • Las Vegas、Nevada、美国、89128
        • Cancer and Blood Specialists-Tenaya
      • Las Vegas、Nevada、美国、89128
        • HealthCare Partners Medical Group Oncology/Hematology-Tenaya
      • Las Vegas、Nevada、美国、89148-2405
        • Las Vegas Cancer Center-Medical Center
      • Las Vegas、Nevada、美国、89149
        • HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills
      • Las Vegas、Nevada、美国、89128
        • Ann M Wierman MD LTD
      • Las Vegas、Nevada、美国、89102
        • Desert West Surgery
      • Las Vegas、Nevada、美国、89103
        • Hope Cancer Care of Nevada
      • Las Vegas、Nevada、美国、89169
        • University Cancer Center
      • Las Vegas、Nevada、美国、89128
        • Oncology Las Vegas - Tenaya
      • Las Vegas、Nevada、美国、89183
        • OptumCare Cancer Care at Fort Apache
      • Pahrump、Nevada、美国、89048
        • Hope Cancer Care of Nevada-Pahrump
      • Reno、Nevada、美国、89502
        • Renown Regional Medical Center
      • Reno、Nevada、美国、89503
        • Saint Mary's Regional Medical Center
      • Reno、Nevada、美国、89509
        • Radiation Oncology Associates
    • New Hampshire
      • Lebanon、New Hampshire、美国、03756
        • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
      • Nashua、New Hampshire、美国、03063
        • Dartmouth Cancer Center - Nashua
    • New Jersey
      • Basking Ridge、New Jersey、美国、07920
        • Memorial Sloan Kettering Basking Ridge
      • Englewood、New Jersey、美国、07631
        • Englewood Hospital and Medical Center
      • Middletown、New Jersey、美国、07748
        • Memorial Sloan Kettering Monmouth
      • Montvale、New Jersey、美国、07645
        • Memorial Sloan Kettering Bergen
      • Paramus、New Jersey、美国、07652
        • The Valley Hospital - Luckow Pavilion
      • Ridgewood、New Jersey、美国、07450
        • Valley Health System Ridgewood Campus
      • Wayne、New Jersey、美国、07470
        • Valley Medical Group - Wayne Multispecialty Practice
    • New Mexico
      • Albuquerque、New Mexico、美国、87109
        • New Mexico Oncology Hematology Consultants
      • Albuquerque、New Mexico、美国、87106
        • University of New Mexico Cancer Center
      • Albuquerque、New Mexico、美国、87110
        • Presbyterian Kaseman Hospital
      • Rio Rancho、New Mexico、美国、87124
        • Presbyterian Rust Medical Center/Jorgensen Cancer Center
    • New York
      • Auburn、New York、美国、13021
        • Hematology Oncology Associates of Central New York-Auburn
      • Buffalo、New York、美国、14263
        • Roswell Park Cancer Institute
      • Camillus、New York、美国、13031
        • Hematology Oncology Associates of CNY at Camillus
      • Commack、New York、美国、11725
        • Memorial Sloan Kettering Commack
      • East Syracuse、New York、美国、13057
        • Hematology Oncology Associates of Central New York-East Syracuse
      • Harrison、New York、美国、10604
        • Memorial Sloan Kettering Westchester
      • New York、New York、美国、10065
        • Memorial Sloan Kettering Cancer Center
      • New York、New York、美国、10029
        • Mount Sinai Hospital
      • Rochester、New York、美国、14642
        • University of Rochester
      • Uniondale、New York、美国、11553
        • Memorial Sloan Kettering Nassau
      • Webster、New York、美国、14580
        • Wilmot Cancer Institute at Webster
    • North Carolina
      • Chapel Hill、North Carolina、美国、27599
        • UNC Lineberger Comprehensive Cancer Center
      • Clinton、North Carolina、美国、28328
        • Southeastern Medical Oncology Center-Clinton
      • Goldsboro、North Carolina、美国、27534
        • Southeastern Medical Oncology Center-Goldsboro
      • Hendersonville、North Carolina、美国、28791
        • Margaret R Pardee Memorial Hospital
      • Jacksonville、North Carolina、美国、28546
        • Southeastern Medical Oncology Center-Jacksonville
      • Kinston、North Carolina、美国、28501
        • ECU Health Oncology Kinston
      • Washington、North Carolina、美国、27889
        • Marion L Shepard Cancer Center - ECU Health Beaufort Hospital
    • North Dakota
      • Bismarck、North Dakota、美国、58501
        • Sanford Bismarck Medical Center
      • Fargo、North Dakota、美国、58122
        • Sanford Roger Maris Cancer Center
      • Fargo、North Dakota、美国、58122
        • Sanford Broadway Medical Center
    • Ohio
      • Beachwood、Ohio、美国、44122
        • UHHS-Chagrin Highlands Medical Center
      • Belpre、Ohio、美国、45714
        • Strecker Cancer Center-Belpre
      • Centerville、Ohio、美国、45459
        • Miami Valley Hospital South
      • Chillicothe、Ohio、美国、45601
        • Adena Regional Medical Center
      • Cleveland、Ohio、美国、44106
        • Case Western Reserve University
      • Columbus、Ohio、美国、43210
        • Ohio State University Comprehensive Cancer Center
      • Columbus、Ohio、美国、43219
        • The Mark H Zangmeister Center
      • Columbus、Ohio、美国、43214
        • Columbus Oncology and Hematology Associates Inc
      • Columbus、Ohio、美国、43228
        • Doctors Hospital
      • Columbus、Ohio、美国、43215
        • Grant Medical Center
      • Dayton、Ohio、美国、45409
        • Miami Valley Hospital
      • Dayton、Ohio、美国、45415
        • Miami Valley Hospital North
      • Dayton、Ohio、美国、45409
        • Premier Blood and Cancer Center
      • Delaware、Ohio、美国、43015
        • Delaware Health Center-Grady Cancer Center
      • Franklin、Ohio、美国、45005-1066
        • Atrium Medical Center-Middletown Regional Hospital
      • Mansfield、Ohio、美国、44903
        • OhioHealth Mansfield Hospital
      • Marietta、Ohio、美国、45750
        • Marietta Memorial Hospital
      • Marion、Ohio、美国、43302
        • OhioHealth Marion General Hospital
      • Maumee、Ohio、美国、43537
        • Toledo Clinic Cancer Centers-Maumee
      • Maumee、Ohio、美国、43537
        • Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
      • Mentor、Ohio、美国、44060
        • UH Seidman Cancer Center at Lake Health Mentor Campus
      • Middleburg Heights、Ohio、美国、44130
        • UH Seidman Cancer Center at Southwest General Hospital
      • Newark、Ohio、美国、43055
        • Licking Memorial Hospital
      • Parma、Ohio、美国、44129
        • University Hospitals Parma Medical Center
      • Perrysburg、Ohio、美国、43551
        • Mercy Health - Perrysburg Hospital
      • Portsmouth、Ohio、美国、45662
        • Southern Ohio Medical Center
      • Toledo、Ohio、美国、43623
        • Mercy Health - Saint Anne Hospital
      • Toledo、Ohio、美国、43623
        • Toledo Clinic Cancer Centers-Toledo
      • Troy、Ohio、美国、45373
        • Upper Valley Medical Center
      • Wadsworth、Ohio、美国、44281
        • University Hospitals Sharon Health Center
      • Westlake、Ohio、美国、44145
        • UH Seidman Cancer Center at Saint John Medical Center
      • Zanesville、Ohio、美国、43701
        • Genesis Healthcare System Cancer Care Center
    • Oklahoma
      • Oklahoma City、Oklahoma、美国、73104
        • University of Oklahoma Health Sciences Center
      • Tulsa、Oklahoma、美国、74146
        • Oklahoma Cancer Specialists and Research Institute-Tulsa
    • Oregon
      • Baker City、Oregon、美国、97814
        • Saint Alphonsus Cancer Care Center-Baker City
      • Clackamas、Oregon、美国、97015
        • Providence Cancer Institute Clackamas Clinic
      • Newberg、Oregon、美国、97132
        • Providence Newberg Medical Center
      • Ontario、Oregon、美国、97914
        • Saint Alphonsus Cancer Care Center-Ontario
      • Portland、Oregon、美国、97213
        • Providence Portland Medical Center
      • Portland、Oregon、美国、97225
        • Providence Saint Vincent Medical Center
    • Pennsylvania
      • Allentown、Pennsylvania、美国、18103
        • Lehigh Valley Hospital-Cedar Crest
      • Bethlehem、Pennsylvania、美国、18017
        • Lehigh Valley Hospital - Muhlenberg
      • East Stroudsburg、Pennsylvania、美国、18301
        • Pocono Medical Center
      • Erie、Pennsylvania、美国、16544
        • Saint Vincent Hospital
      • Hazleton、Pennsylvania、美国、18201
        • Lehigh Valley Hospital-Hazleton
      • Jefferson Hills、Pennsylvania、美国、15025
        • Jefferson Hospital
      • Monroeville、Pennsylvania、美国、15146
        • Forbes Hospital
      • Philadelphia、Pennsylvania、美国、19111
        • Fox Chase Cancer Center
      • Philadelphia、Pennsylvania、美国、19107
        • Thomas Jefferson University Hospital
      • Philadelphia、Pennsylvania、美国、19140
        • Temple University Hospital
      • Pittsburgh、Pennsylvania、美国、15212
        • Allegheny General Hospital
      • Pittsburgh、Pennsylvania、美国、15224
        • West Penn Hospital
      • Wexford、Pennsylvania、美国、15090
        • Wexford Health and Wellness Pavilion
    • South Carolina
      • Boiling Springs、South Carolina、美国、29316
        • Prisma Health Cancer Institute - Spartanburg
      • Easley、South Carolina、美国、29640
        • Prisma Health Cancer Institute - Easley
      • Greenville、South Carolina、美国、29605
        • Prisma Health Cancer Institute - Faris
      • Greenville、South Carolina、美国、29615
        • Prisma Health Cancer Institute - Eastside
      • Greenville、South Carolina、美国、29605
        • Prisma Health Cancer Institute - Butternut
      • Greer、South Carolina、美国、29650
        • Prisma Health Cancer Institute - Greer
      • Seneca、South Carolina、美国、29672
        • Prisma Health Cancer Institute - Seneca
    • South Dakota
      • Sioux Falls、South Dakota、美国、57117-5134
        • Sanford USD Medical Center - Sioux Falls
      • Sioux Falls、South Dakota、美国、57104
        • Sanford Cancer Center Oncology Clinic
    • Utah
      • Farmington、Utah、美国、84025
        • Farmington Health Center
      • Salt Lake City、Utah、美国、84112
        • Huntsman Cancer Institute/University of Utah
      • Salt Lake City、Utah、美国、84106
        • University of Utah Sugarhouse Health Center
    • Washington
      • Seattle、Washington、美国、98101
        • Virginia Mason Medical Center
    • West Virginia
      • Huntington、West Virginia、美国、25701
        • Edwards Comprehensive Cancer Center
      • Morgantown、West Virginia、美国、26506
        • West Virginia University Healthcare
    • Wisconsin
      • Appleton、Wisconsin、美国、54911
        • ThedaCare Regional Cancer Center
      • Ashland、Wisconsin、美国、54806
        • Duluth Clinic Ashland
      • Eau Claire、Wisconsin、美国、54701
        • Marshfield Medical Center-EC Cancer Center
      • Madison、Wisconsin、美国、53792
        • University of Wisconsin Carbone Cancer Center - University Hospital
      • Marshfield、Wisconsin、美国、54449
        • Marshfield Medical Center-Marshfield
      • Minocqua、Wisconsin、美国、54548
        • Marshfield Medical Center - Minocqua
      • Mukwonago、Wisconsin、美国、53149
        • ProHealth D N Greenwald Center
      • New Richmond、Wisconsin、美国、54017
        • Cancer Center of Western Wisconsin
      • Oconomowoc、Wisconsin、美国、53066
        • ProHealth Oconomowoc Memorial Hospital
      • Rice Lake、Wisconsin、美国、54868
        • Marshfield Medical Center-Rice Lake
      • Stevens Point、Wisconsin、美国、54482
        • Marshfield Medical Center-River Region at Stevens Point
      • Waukesha、Wisconsin、美国、53188
        • UW Cancer Center at ProHealth Care
      • Waukesha、Wisconsin、美国、53188
        • ProHealth Waukesha Memorial Hospital
      • Weston、Wisconsin、美国、54476
        • Marshfield Medical Center - Weston
    • Wyoming
      • Cody、Wyoming、美国、82414
        • Billings Clinic-Cody
      • Sheridan、Wyoming、美国、82801
        • Welch Cancer Center

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Documentation of Disease:

    • Histologic Documentation: Well- or moderately-differentiated neuroendocrine tumors of pancreatic and non-pancreatic (i.e. carcinoid) origin by local pathology

      • The pathology report must state ONE of the following: 1) well- or moderately-differentiated neuroendocrine tumor, 2) low- or intermediate-grade neuroendocrine tumor, or 3) carcinoid tumor or atypical carcinoid tumor; documentation of histology from a primary or metastatic site is allowed
      • Patients with poorly differentiated neuroendocrine carcinoma, high-grade neuroendocrine carcinoma without specification of differentiation status, adenocarcinoid tumor, or goblet cell carcinoid tumor are not eligible. Patients with well-differentiated grade 3 neuroendocrine tumor are eligible
    • Stage: Locally advanced/unresectable or metastatic disease

    • Tumor Site: Histological documentation of neuroendocrine tumor of pancreatic, gastrointestinal (GI), lung, thymus, other, or unknown primary site; GI, lung, thymus, other, and unknown primary NETs will enroll in the carcinoid tumor cohort of the study

      • Functional (i.e., associated with symptoms or clinical syndrome related to hormone secretion by tumor) or nonfunctional tumors are allowed
    • Radiologic Evaluation: Target lesions must have shown evidence of disease progression by Response Evaluation Criteria in Solid Tumors (RECIST) version (v)1.1 criteria in the 12 months prior to registration; the radiologic images, imaging reports, and clinic notes indicating growth of existing lesions, development of new lesions, or treatment changes must be submitted

  • Measurable Disease

    • Patients must have measurable disease per RECIST 1.1 by computer tomography (CT) scan or magnetic resonance imaging (MRI)
    • Lesions must be accurately measured in at least one dimension (longest diameter to be recorded) as >= 1 cm with CT or MRI (or >= 1.5 cm for lymph nodes); non-measurable disease includes disease smaller than these dimensions or lesions considered truly non-measurable including: leptomeningeal disease, ascites, pleural or pericardial effusion, lymphangitic involvement of skin or lung
  • Prior Treatment

    • Patient must have experienced disease progression after receiving or intolerance leading to treatment discontinuation of at least one Food and Drug Administration (FDA)-approved line of therapy (except somatostatin analogs); prior lines of therapy must include one of the following: everolimus, sunitinib, or lutetium Lu 177 dotatate in patients with pancreatic NET; everolimus in patients with lung NET; everolimus or lutetium Lu 177 dotatate in patients with gastrointestinal NET
    • Prior treatment (except somatostatin analogs) with biologic therapy, immunotherapy, chemotherapy, investigational agent for malignancy, and/or radiation must be completed at least 28 days prior to registration
    • Prior treatment with somatostatin analogs is allowed, and continuation of treatment with somatostatin analogs while on cabozantinib/placebo is allowed provided that the patient has been on a stable dose for at least two months
    • Prior systemic treatment with radionuclide therapy must be completed at least 6 weeks prior to registration
    • Prior treatment with hepatic artery embolization (including bland embolization, chemoembolization, and selective internal radiation therapy) or ablative therapies is allowed if measurable disease remains outside of the treated area or if there is documented disease progression in a treated site; prior liver-directed or other ablative treatment must be completed at least 28 days prior to registration
    • Prior treatment with cabozantinib is not allowed
    • Patients should have resolution of any toxic effects of prior therapy (except alopecia and fatigue) to National Cancer Institute (NCI) CTCAE, version 5.0, grade 1 or less
    • Patients must have completed any major surgery at least 12 weeks prior to registration and any minor surgery (including uncomplicated tooth extractions) at least 28 days prior to registration; complete wound healing from major surgery must have occurred at least 28 days prior to registration, and complete wound healing from minor surgery must have occurred at least 10 days prior to registration
  • Patient History

    • No class III or IV congestive heart failure (CHF) within 6 months of registration
    • No clinically significant cardiac arrhythmia within 6 months of registration
    • No unstable angina or myocardial infarction (MI) within 6 months of registration
    • No thromboembolic events within 6 months of registration (including [incl.] stroke, transient ischemic attack [TIA], deep vein thrombosis [DVT], & pulmonary embolism [PE])
    • No known history of congenital long QT syndrome
    • No uncontrolled hypertension within 14 days of registration (defined as systolic blood pressure [SBP] >= 150 mmHg and/or diastolic blood pressure [DBP] >= 90 mmHg despite optimal medical management)
    • No clinically significant GI bleeding within 6 months of registration
    • No clinically significant gastrointestinal abnormalities that may increase the risk for gastrointestinal bleeding within 6 months of registration including, but not limited to: active peptic ulcer, known endoluminal metastatic lesion(s) with history of bleeding, inflammatory bowel disease, or other gastrointestinal conditions with increased risk of perforation
    • No GI perforation within 6 months of registration
    • No known tumor with invasion into the GI tract from the outside causing increased risk of perforation or bleeding within 28 days of registration
    • No radiologic or clinical evidence of pancreatitis
    • No known cavitary lung lesions
    • No known endobronchial lesions involving the main or lobar bronchi and/or lesions infiltrating major pulmonary vessels that increase the risk of pulmonary hemorrhage; (CT with contrast is recommended to evaluate such lesions)
    • No hemoptysis greater than 1/2 teaspoon (2.5 mL) or any other signs of pulmonary hemorrhage within the 3 months prior to registration
    • No known tumor invading or encasing any major blood vessels
    • No history of non-healing wounds or ulcers within 28 days of registration
    • No history of fracture within 28 days of registration
    • No brain metastases or cranial epidural disease unless adequately treated, stable, and off steroid support for at least 4 weeks prior to registration
    • No known medical condition causing an inability to swallow oral formulations of agents
    • No history of allergic reaction attributed to compounds of similar chemical or biological composition to cabozantinib/placebo
    • No "currently active" second malignancy other than non-melanoma skin cancers or cervical carcinoma in situ; patients are not considered to have a "currently active" malignancy if they have completed therapy and are free of disease for >= 3 years
  • Concomitant Medications

    • Other planned concurrent investigational agents or other tumor directed therapies (chemotherapy, radiation) are not allowed while on this study
    • Concurrent use of somatostatin analogs while on cabozantinib/placebo is allowed provided that the patient has been on a stable dose for at least two months
    • Full dose oral anticoagulation/antiplatelet therapy is not permitted; low dose aspirin =< 81 mg/day is allowed; anticoagulation with therapeutic doses of low molecular weight heparin (LMWH) is allowed in patients who are on a stable dose of LMWH for at least 6 weeks prior to registration; treatment with warfarin is not allowed; anticoagulation in patients with brain metastases is not permitted
    • Chronic concomitant treatment with strong inhibitors of CYP3A4 is not allowed; patients must discontinue the drug at least 14 days prior to registration on the study
    • Chronic concomitant treatment with strong CYP3A4 inducers is not allowed; patients must discontinue the drug at least 14 days prior to registration on the study
  • Not pregnant and not nursing

    • Women of childbearing potential must have a negative pregnancy test done =< 14 days prior to registration
    • A female of childbearing potential is a sexually mature female who: 1) has not undergone a hysterectomy or bilateral oophorectomy; or 2) has not been naturally postmenopausal for at least 12 consecutive months (i.e. has had menses at any time in the preceding 12 consecutive months)
  • Age >= 18 years

  • Eastern Cooperative Oncology Group (ECOG) performance status: 0-2

  • Absolute neutrophil count (ANC) >= 1,500/mm^3

  • Hemoglobin >= 9 g/dL

  • Platelet count >= 100,000/mm^3

  • Prothrombin time (PT)/ international normalized ratio (INR), partial thromboplastin time (PTT) < 1.3 x upper limit of normal (ULN)

  • Aspartate aminotransferase (AST)/ alanine aminotransferase (ALT) =< 3 x ULN

  • Total bilirubin =< 1.5 x ULN

    • Except in the case of Gilbert disease, in which case total bilirubin must be =< 3 x ULN
  • Creatinine =< 1.5 mg/dL OR creatinine clearance >= 45 mL/min

  • Albumin >= 2.8 g/dL

  • Potassium within normal limits (WNL)

    • Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal thyroid stimulating hormone (TSH), if free T4 is normal and patient is clinically euthyroid, patient is eligible
  • Phosphorus WNL

    • Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal TSH, if free T4 is normal and patient is clinically euthyroid, patient is eligible
  • Calcium WNL

    • Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal TSH, if free T4 is normal and patient is clinically euthyroid, patient is eligible
  • Magnesium WNL

    • Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal TSH, if free T4 is normal and patient is clinically euthyroid, patient is eligible
  • Urine protein to creatinine (UPC) ratio =< 1

  • QT interval corrected for heart rate using Fridericia's formula (QTcF) =< 500 msec

  • TSH WNL

    • Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal TSH, if free T4 is normal and patient is clinically euthyroid, patient is eligible

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
实验性的:Arm I (cabozantinib S-malate)

Patients receive cabozantinib S-malate PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo blood and urine sample collection, and CT, MRI, and/or x-ray imaging during screening and on study.

Ancillary studies

其他名称:
  • 生活质量评估

Undergo CT

其他名称:
  • CT
  • 猫
  • 电脑扫描
  • 计算机轴向断层扫描
  • 计算机断层扫描
  • CT扫描
  • 断层扫描
  • 计算机轴向断层扫描(程序)
  • 计算机断层扫描 (CT) 扫描
  • 诊断猫扫描
  • 诊断猫扫描服务类型

Undergo MRI

其他名称:
  • 核磁共振
  • 磁共振
  • 磁共振成像扫描
  • 医学影像、磁共振/核磁共振
  • 先生
  • 磁共振成像
  • 核磁共振成像扫描
  • 核磁共振成像
  • 磁共振成像 (MRI)
  • 磁共振成像(程序)
  • 结构核磁共振

Given PO

其他名称:
  • BMS-907351
  • 卡博美泰
  • 彗星
  • XL-184
  • XL184
  • XL 184

Undergo blood and urine sample collection

其他名称:
  • 生物样本采集
  • 收集的生物样本
  • 标本采集
  • 样本收集

Undergo x-ray

其他名称:
  • 常规 X 射线
  • 诊断放射学
  • 医学成像、X 射线
  • 放射成像
  • 造影
  • RG
  • 静态X射线
  • X射线
  • 平片射线照片
  • 射线照相成像程序(程序)
安慰剂比较:Arm II (placebo)

Patients receive placebo PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo blood and urine sample collection, and CT, MRI, and/or x-ray imaging during screening and on study. Patients may crossover to receive cabozantinib S-malate at the time of disease progression.

Ancillary studies

其他名称:
  • 生活质量评估

Undergo CT

其他名称:
  • CT
  • 猫
  • 电脑扫描
  • 计算机轴向断层扫描
  • 计算机断层扫描
  • CT扫描
  • 断层扫描
  • 计算机轴向断层扫描(程序)
  • 计算机断层扫描 (CT) 扫描
  • 诊断猫扫描
  • 诊断猫扫描服务类型

Undergo MRI

其他名称:
  • 核磁共振
  • 磁共振
  • 磁共振成像扫描
  • 医学影像、磁共振/核磁共振
  • 先生
  • 磁共振成像
  • 核磁共振成像扫描
  • 核磁共振成像
  • 磁共振成像 (MRI)
  • 磁共振成像(程序)
  • 结构核磁共振

Given PO

Undergo blood and urine sample collection

其他名称:
  • 生物样本采集
  • 收集的生物样本
  • 标本采集
  • 样本收集

Undergo x-ray

其他名称:
  • 常规 X 射线
  • 诊断放射学
  • 医学成像、X 射线
  • 放射成像
  • 造影
  • RG
  • 静态X射线
  • X射线
  • 平片射线照片
  • 射线照相成像程序(程序)

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Progression-free Survival (PFS)
大体时间:36 months

Will be assessed per Response Evaluation Criteria in Solid Tumors 1.1 determined by retrospective independent central review. Will be compared between treatment arms using the stratified log rank test at one-sided level 0.025. The stratification factors will be used for the analysis. The hazard ratio (HR) for PFS will be estimated using a stratified Cox proportional hazards model, and the 95% confidence interval (CI) for the HR will be provided. Results from an unstratified analysis will also be provided. Kaplan-Meier methodology will be used to estimate the median PFS for each treatment arm, and Kaplan-Meier curves will be produced. Brookmeyer Crowley methodology will be used to construct the 95% CI for the median PFS for each treatment arm.

36 months

次要结果测量

结果测量
措施说明
大体时间
Overall Survival (OS)
大体时间:60 months

The analyses for OS will follow intent-to-treat (ITT) principle and will be conducted separately within each cohort (pancreatic neuroendocrine tumor [NET] and carcinoid tumor). The distribution of OS will be estimated using the method of Kaplan-Meier. The median OS, along with the 95% CI, will be estimated by the two treatment groups. Overall survival will be compared between treatment arms using the stratified log-rank test at a one-sided cumulative 2.5% level of significance. The stratified Cox regression will be used to estimate the HR of OS, along with the 95% CI. A hierarchical approach will be used to control for family-wise type-I error rate, therefore OS will be formally statistically tested only if the primary efficacy endpoint, PFS, is statistically significantly different between the two treatment groups.

60 months
Number of Patients Experiencing Grade 3+ Adverse Events (AEs) Graded According to the Common Terminology Criteria for Adverse Events (CTCAE) and Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
大体时间:60 months

For CTCAE data, the frequency tables will be reviewed to determine the patterns. The overall adverse event rates will be compared between treatment groups using Chi-square test (or Fisher's exact test if the data in contingency table is sparse). PRO-CTCAE data will, at minimum, be analyzed similarly to CTCAE data. The initial analysis of each PRO-CTCAE item will use all available scores in an analysis which mirrors the approach used for the CTCAE data. Supplemental analysis will use model-based multiple imputation incorporating baseline patient characteristics and physician-rated performance status. CTCAE data may be incorporated as auxiliary data into multiple imputation models for AEs which are captured by both PRO-CTCAE and CTCAE. Results from supplemental analysis will be descriptively compared to the results of the initial analysis to assess the robustness of results to missing data. Additional analyses of PRO-CTCAE data beyond those specified above may be undertaken.

60 months
Radiographic Response Rate
大体时间:36 months

Will be defined as the proportion of patients in each arm whose best response is either complete response (CR) or partial response (PR). Radiographic response rate for both cohorts: the analyses for confirmed radiographic response rate will follow the ITT principle and will be conducted separately within each cohort (pancreatic NET and carcinoid tumor). The proportion of patients with either confirmed CR or confirmed PR as their best response will be estimated using point estimates and 95% confidence intervals. Radiographic response rate will be compared between treatment arms using the 2-sample z-test to compare sample proportion at a one-sided 2.5% level of significance.

36 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Jennifer A Chan、Alliance for Clinical Trials in Oncology

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2018年10月26日

初级完成 (实际的)

2023年8月23日

研究完成 (估计的)

2027年9月1日

研究注册日期

首次提交

2017年12月15日

首先提交符合 QC 标准的

2017年12月15日

首次发布 (实际的)

2017年12月18日

研究记录更新

最后更新发布 (实际的)

2026年11月13日

上次提交的符合 QC 标准的更新

2026年11月11日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

是的

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅